CAPRICOR THERAPEUTICS, INC. Proceeds from Sale and Maturity of Marketable Securities
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Proceeds from Sale and Maturity of Marketable Securities of $64.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-14
- CAPRICOR THERAPEUTICS, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-06-30 was $33.00M, a 56.58% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2026-03-31 was $31.00M, a 28.27% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-12-31 was $63.21M, a 278.14% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. proceeds from sale and maturity of marketable securities for the quarter ending 2025-09-30 was $78.18M, a 257.66% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. proceeds from sale and maturity of marketable securities for fiscal 2025 was $260.60M, a 177.83% increase from fiscal 2024.
- CAPRICOR THERAPEUTICS, INC. proceeds from sale and maturity of marketable securities for fiscal 2024 was $93.80M, a 10.33% decline from fiscal 2023.
- CAPRICOR THERAPEUTICS, INC. proceeds from sale and maturity of marketable securities for fiscal 2023 was $104.60M, a 26.78% increase from fiscal 2022.
- CAPRICOR THERAPEUTICS, INC. proceeds from sale and maturity of marketable securities for fiscal 2022 was $82.51M.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 6 month as first filed | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month | Proceeds from Sale and Maturity of Marketable Securities 102 month | Proceeds from Sale and Maturity of Marketable Securities 105 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $64.00M 10-Q · filed 2026-08-14 | $127.21M derived: sum of 3 quarters · filed 2026-08-14 | $205.39M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $31.00M 10-Q · filed 2026-05-13 | $94.21M derived: sum of 2 quarters · filed 2026-05-13 | $172.39M derived: sum of 3 quarters · filed 2026-05-13 | $248.38M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $63.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $141.39M derived: sum of 2 quarters · filed 2026-03-17 | $217.38M derived: sum of 3 quarters · filed 2026-08-14 | $260.60M 10-K · filed 2026-03-17 | |||
| 2025-09-30 | $78.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $154.17M derived: sum of 2 quarters · filed 2026-08-14 | $197.38M 10-Q · filed 2025-11-10 | $214.10M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $76.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $119.21M 10-Q · filed 2026-08-14 | $135.92M derived: sum of 3 quarters · filed 2026-08-14 | $157.78M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $43.21M 10-Q · filed 2026-05-13 | $59.93M derived: sum of 2 quarters · filed 2026-05-13 | $81.79M derived: sum of 3 quarters · filed 2026-05-13 | $112.64M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $16.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $38.57M derived: sum of 2 quarters · filed 2026-03-17 | $69.42M derived: sum of 3 quarters · filed 2026-03-17 | $93.80M 10-K · filed 2026-03-17 | |||
| 2024-09-30 | $21.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $52.71M derived: sum of 2 quarters · filed 2025-11-10 | $77.08M 10-Q · filed 2025-11-10 | $96.72M derived: sum of 4 quarters · filed 2025-11-10 | |||
| 2024-06-30 | $30.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $55.22M 10-Q · filed 2025-08-11 | $74.86M derived: sum of 3 quarters · filed 2025-08-11 | $103.02M derived: sum of 4 quarters · filed 2025-08-11 | |||
| 2024-03-31 | $24.37M 10-Q · filed 2025-05-14 | $44.02M derived: sum of 2 quarters · filed 2025-05-14 | $72.17M derived: sum of 3 quarters · filed 2025-05-14 | $96.93M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $19.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $47.80M derived: sum of 2 quarters · filed 2025-03-26 | $72.55M derived: sum of 3 quarters · filed 2025-03-26 | $104.60M 10-K · filed 2025-03-26 | |||
| 2023-09-30 | $28.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $52.91M derived: sum of 2 quarters · filed 2024-11-14 | $84.95M 10-Q · filed 2024-11-14 | $123.36M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | $24.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $56.80M 10-Q · filed 2024-08-08 | $95.21M derived: sum of 3 quarters · filed 2024-08-08 | $125.29M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $32.05M 10-Q · filed 2024-05-14 | $70.45M derived: sum of 2 quarters · filed 2024-05-14 | $100.54M derived: sum of 3 quarters · filed 2024-05-14 | $114.55M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $38.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $68.49M derived: sum of 2 quarters · filed 2024-03-11 | $82.51M derived: sum of 3 quarters · filed 2024-03-11 | $82.51M 10-K · filed 2024-03-11 | |||
| 2022-09-30 | $30.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $44.10M derived: sum of 2 quarters · filed 2023-11-14 | $44.10M 10-Q · filed 2023-11-14 | $44.10M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $14.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $14.01M 10-Q · filed 2023-08-08 | $14.01M derived: sum of 3 quarters · filed 2023-08-08 | $14.01M derived: sum of 4 quarters · filed 2023-08-08 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-05-12 | $0.00 derived: sum of 3 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $0.00 derived: sum of 2 quarters · filed 2023-03-17 | $0.00 10-K · filed 2023-03-17 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-12 | ||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $0.00 derived: sum of 3 quarters · filed 2022-03-11 | $12.12M 10-K · filed 2022-03-11 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $12.12M 10-Q · filed 2021-11-12 | $12.12M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $12.12M 10-Q · filed 2021-08-13 | $12.12M derived: sum of 3 quarters · filed 2021-08-13 | $12.12M derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $12.12M 10-Q · filed 2021-05-14 | $12.12M derived: sum of 2 quarters · filed 2021-05-14 | $12.12M derived: sum of 3 quarters · filed 2021-05-14 | $12.12M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $0.00 derived: sum of 2 quarters · filed 2021-03-15 | $0.00 derived: sum of 3 quarters · filed 2021-03-15 | $3.00M 10-K · filed 2021-03-15 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $3.00M 10-Q · filed 2020-11-13 | $9.00M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $3.00M 10-Q · filed 2020-08-10 | $9.00M derived: sum of 3 quarters · filed 2020-08-10 | $15.00M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | $3.00M 10-Q · filed 2020-05-15 | $9.00M derived: sum of 2 quarters · filed 2020-05-15 | $15.00M derived: sum of 3 quarters · filed 2020-05-15 | $21.00M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $12.00M derived: sum of 2 quarters · filed 2020-03-27 | $18.00M derived: sum of 3 quarters · filed 2020-03-27 | $23.00M 10-K · filed 2020-03-27 | |||
| 2018-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $12.00M derived: sum of 2 quarters · filed 2019-11-08 | $17.00M 10-Q · filed 2019-11-08 | $22.00M derived: sum of 4 quarters · filed 2019-11-08 | |||
| 2018-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $11.00M 10-Q · filed 2019-08-08 | $16.00M derived: sum of 3 quarters · filed 2019-08-08 | $20.00M derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | $5.00M 10-Q · filed 2019-05-14 | $10.00M derived: sum of 2 quarters · filed 2019-05-14 | $14.00M derived: sum of 3 quarters · filed 2019-05-14 | $21.00M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $9.00M derived: sum of 2 quarters · filed 2019-03-29 | $16.00M derived: sum of 3 quarters · filed 2019-03-29 | $24.00M 10-K · filed 2019-03-29 | |||
| 2017-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $11.00M derived: sum of 2 quarters · filed 2018-11-14 | $19.00M 10-Q · filed 2018-11-14 | $21.50M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $15.00M 10-Q · filed 2018-08-13 | $17.50M derived: sum of 3 quarters · filed 2018-08-13 | $20.00M derived: sum of 4 quarters · filed 2018-08-13 | |||
| 2017-03-31 | $8.00M 10-Q · filed 2018-05-14 | $10.50M derived: sum of 2 quarters · filed 2018-05-14 | $13.00M derived: sum of 3 quarters · filed 2018-05-14 | $13.00M derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $5.00M derived: sum of 2 quarters · filed 2018-03-22 | $5.00M derived: sum of 3 quarters · filed 2018-03-22 | $13.00M 10-K · filed 2018-03-22 | |||
| 2016-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $2.50M derived: sum of 2 quarters · filed 2017-11-14 | $10.50M 10-Q · filed 2017-11-14 | $15.50M derived: sum of 4 quarters · filed 2017-11-14 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $8.00M 10-Q · filed 2017-08-14 | $13.00M derived: sum of 3 quarters · filed 2017-08-14 | $18.00M derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $8.00M 10-Q · filed 2017-05-15 | $13.00M derived: sum of 2 quarters · filed 2017-05-15 | $18.00M derived: sum of 3 quarters · filed 2017-05-15 | $18.00M derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $10.00M derived: sum of 2 quarters · filed 2017-03-16 | $10.00M derived: sum of 3 quarters · filed 2017-03-16 | $10.00M 10-K · filed 2017-03-16 | |||
| 2015-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $5.00M derived: sum of 2 quarters · filed 2016-11-14 | $5.00M 10-Q · filed 2016-11-14 | $5.33M derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | $326.93K derived: sum of 3 quarters · filed 2016-08-15 | $326.67K derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-13 | $326.93K derived: sum of 2 quarters · filed 2016-05-13 | $326.67K derived: sum of 3 quarters · filed 2016-05-13 | $99.63K derived: sum of 4 quarters · filed 2016-05-13 | |||
| 2014-12-31 | $326.93K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $326.67K derived: sum of 2 quarters · filed 2016-03-30 | $99.63K derived: sum of 3 quarters · filed 2016-03-30 | $327.47K 10-K · filed 2016-03-30 | |||
| 2014-09-30 | -$260.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$227.29K derived: sum of 2 quarters · filed 2015-11-13 | $549.00 10-Q · filed 2015-11-13 | $1.30M derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | -$227.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $809.00 10-Q · filed 2015-08-14 | $327.73K 10-Q · filed 2014-08-14 | $1.30M derived: sum of 3 quarters · filed 2015-08-14 | $2.43M derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | $227.84K 10-Q · filed 2015-05-13 | $1.52M derived: sum of 2 quarters · filed 2015-05-13 | $2.65M derived: sum of 3 quarters · filed 2015-05-13 | $3.85M derived: sum of 4 quarters · filed 2015-05-13 | $4.34M 10-Q · filed 2014-05-15 | ||
| 2013-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $2.43M derived: sum of 2 quarters · filed 2015-03-16 | $3.63M derived: sum of 3 quarters · filed 2015-03-16 | $4.11M 10-K · filed 2015-03-16 | $4.11M 10-K · filed 2014-03-31 | ||
| 2013-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $2.33M derived: sum of 2 quarters · filed 2014-11-14 | $2.82M 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $1.69M 10-Q · filed 2014-08-14 | |||||
| 2013-03-31 | $488.00K 10-Q · filed 2014-05-15 | ||||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |